A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group

Journal of the Neurological Sciences
D McGuireM A Ross

Abstract

We previously demonstrated a significant relationship (P<0.0001) between maximum voluntary isometric contraction (MVC) plus pulmonary function scores (the Tufts Quantitative Neuromuscular Exam Combination Megascore (TQNE CM)), and the Sickness Impact Profile (SIP) in a cohort of 524 ALS patients. Because the 136-item SIP questionnaire can be difficult to administer in this population, we examined SIP subscales and clinically derived item sets in relation to the TQNE CM in an effort to define a briefer measure of quality of life for use in clinical trials. Two 'Mini-SIP' indices performed as well as the overall SIP in reflecting the impact of muscle weakness on ALS patients' quality of life: a combination of two SIP subscales ('SIP-33'), and a 19-item set of questions independently chosen by a panel of ALS specialists ('SIP/ALS-19'). Either index potentially could be useful in ALS clinical trials. The SIP/ALS-19 is currently being used in a National ALS data base, providing an opportunity to evaluate its utility prospectively against other QOL measures in ALS patients.

Citations

Oct 7, 2005·Journal of Neurology·Dörthe RöttigStephan Zierz
Sep 30, 2004·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Barbara A BremerStephanie H Felgoise
Jul 16, 2008·Physical Medicine and Rehabilitation Clinics of North America·Mark B Bromberg
Jan 7, 2004·Acta Neurologica Scandinavica·M PiccininniA Pizzi
Oct 7, 2015·Frontiers in Psychology·Tamara MatuzAndrea Kübler
Jul 5, 2005·Expert Opinion on Investigational Drugs·M B Bromberg
Nov 20, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Stephanie H FelgoiseZachary Simmons
Aug 25, 2004·American Journal of Medical Genetics. Part a·Joanna H FanosRobert G Miller
Dec 20, 2007·Journal of Clinical Neuromuscular Disease·Mark B Bromberg
Aug 30, 2008·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Joanna EptonCrispin Jenkinson
Feb 16, 2011·Journal of Clinical Neuromuscular Disease·Tulio E BertoriniYingjun D Li
Feb 8, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Julia CuppHelen E Stephens
Oct 30, 2010·Journal of Evaluation in Clinical Practice·Pauline BanksRichard K H Petty
Feb 13, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·D WolfeJ C Glorioso
Sep 16, 1999·Experimental Neurology·D WolfeJ C Glorioso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.